🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to learn if serum biomarkers can better ...
Status
Completed
Location
Hospital Universitario "Dr. José Eleuterio González"
Start Date
2022-06-04
Trial ID
NCT07688733
Treatments Being Tested
Lupus nephritis (LN) develops in 30-60% of systemic lupus erythematosus (SL...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-01
Trial ID
NCT07505576
The goal of this clinical trial is to evaluate the safety and effectiveness...
Status
Recruiting
Location
Medical University of South Carolina
Start Date
2025-01-07
Trial ID
NCT06737380
Treatments Being Tested
The NEPHRO-IBD study is a multicenter prospective observational study desig...
Status
Recruiting
Location
National Medical Institute of the Ministry of the Interior and Administration, Clinic of Gastroenterology and Internal Diseases
Start Date
2025-11-20
Trial ID
NCT07593352
Study includes 5 visits: Screening, Baseline/Surgery, and 14 days, 3 months...
Status
Completed
Location
Hillel Yaffe Medical Center
Start Date
2022-01-19
Trial ID
NCT04986917
This phase II trial tests the safety, side effects and best dose of BMS-986...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2025-12-12
Trial ID
NCT07226856
Type 1 diabetes (T1D) is characterized by absolute insulin deficiency. Alth...
Status
Recruiting
Location
Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University
Start Date
2022-05-01
Trial ID
NCT05359796
This Phase 1b, open-label, single-center, prospective trial will be assessi...
Status
Completed
Location
Royal London Hospital-Clinical Research Facility-11D (11th Floor) Whitechapel, London, E1 1FR,
Start Date
2023-03-06
Trial ID
NCT05956314
Treatments Being Tested
Background and aim: ABO blood groups are biologically plausible modulators ...
Status
Completed
Location
Faculty of medicine
Start Date
2024-05-01
Trial ID
NCT07757269
With increasing survival rates in pediatric oncology, reports of long-term ...
Status
Recruiting
Location
Department of Pediatrics and Adolescent Medicine
Start Date
2025-11-19
Trial ID
NCT07313878